The authoritative source for research information and outputs is Elsevier Scopus, with researcher profile verification from the Deanship of Scientific Research.
المخرجات
Research outputs
Articles, reviews, conference papers and book chapters, indexed by DOI and linked to University researchers.
BACKGROUND: Polypharmacy and potential drug-drug interactions (pDDIs) are major challenges in the management of elderly patients with multiple comorbidities, often leading to adverse drug events and increased healthcare burden. AIM: This study aimed to determine the prevalence and patterns of polypharmacy and pDDIs among elderly patients attending Yenepoya Medical College and Hospital, Mangalore, India. METHODS: A cross-sectional study was conducted from January to June 2023 among 310 elderly patients (aged ≥60 years) selected through simple random sampling from both in-patient and out-patient departments. Polypharmacy was defined as the concurrent use of ≥5 medications, and excessive polypharmacy as ≥9 medications. Drug interaction screening was performed using UpToDate and Medscape interaction checker tools. Statistical analyses included descriptive statistics, t-tests, chi-square tests, and regression analysis, with significance set at p < 0.05. RESULTS: The prevalence of polypharmacy was slightly higher in females (53.84%) than males (51.94%), with the highest rates observed in the 70-79 age group (48.88%). Most patients experienced moderate (50%) drug interactions. A significant gender difference was observed in the number of drugs prescribed at treatment (p = 0.0032), but not at discharge. Regression analysis identified gender (p = 0.018) and inpatient status (p < 0.001) as significant predictors of polypharmacy, while age was not (p = 0.719). CONCLUSION: This study reveals a high prevalence of polypharmacy among elderly patients attending Yenepoya Medical College and Hospital. Polypharmacy was found to be more prevalent among female patients, older age groups, and in inpatient wards. The distribution of drug interactions revealed a pervasive nature across various degrees, with moderate interactions being the most common. Future research should use larger samples, and diverse populations to better understand polypharmacy, drug interactions, and outcomes.
Adhesive small bowel obstruction (aSBO) is a common cause of emergency surgical admission, and the optimal initial management between early surgery and conservative non-operative management (NOM) remains debated, particularly regarding recurrence and short-term safety. This systematic review aimed to evaluate short- and long-term outcomes of early operative management compared with conservative treatment for aSBO in adult and paediatric populations. A systematic search of MEDLINE, Embase, Scopus, and Cochrane CENTRAL was conducted from inception to 2025 in accordance with PRISMA guidelines. Nine studies were included. In stable adults, NOM was generally safe with comparable short-term complication and mortality rates to early surgery; however, prolonged delays following NOM failure were associated with increased morbidity and bowel resection. Long-term outcomes consistently favoured early operative management, demonstrating a 40-60% relative reduction in recurrence. Water-soluble contrast protocols improved diagnostic accuracy and NOM success, while specific radiological findings predicted failure. In paediatric patients, NOM was effective in many cases, but infants under one year of age had a higher likelihood of requiring surgery, and delays beyond 48 hours increased bowel resection rates. Overall, NOM is safe for selected patients, but early surgery offers superior long-term recurrence outcomes.
adhesive small bowel obstructionearly surgical interventionconservative treatmentrecurrence
The Lancet Child & Adolescent Health · vol. 10 (10) · 731-754
BACKGROUND: The Asia Pacific region is home to more than half of the world's 1·93 billion adolescents (aged 10-24 years). Addressing adolescent health in this region is of global importance, but to date a systematic analysis of key contributors to disease in adolescents has not been done, which is a barrier to responsive action. This systematic analysis of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2023 aims to provide a comprehensive assessment of adolescent health across the Asia Pacific region, at both the subregional and national levels, encompassing burden of disease, mortality, and prevalence of adolescent risk factors. METHODS: As part of GBD 2023, we obtained estimates for cause-specific mortality, disability-adjusted life-years (DALYs), and risk factor prevalence by sex for adolescents aged 10-24 years and 5-year age groups (10-14 years, 15-19 years, and 20-24 years) across 44 countries and territories (hereafter referred to collectively as Asia Pacific), grouped by seven UN subregions, from 2000 to 2023. We extracted GBD 2023 population counts and estimates of number and rate (per 100 000 population) for mortality and disease burden (DALYs). Risk prevalence estimates were obtained directly from the Institute for Health Metrics and Evaluation, and binge drinking estimates were sourced from WHO. Estimates are reported with 95% uncertainty intervals (UIs) where possible. UIs were estimated by running 250 draws of the posterior distribution, ordering the draws, and selecting the 2·5th and 97·5th percentiles for each metric. FINDINGS: In 2023, in adolescents across Asia Pacific, there were 637 496 deaths and a total disease burden of 115·8 million DALYs, representing 34·1% of global adolescent deaths and 40·6% of the global adolescent burden of disease. Non-communicable diseases (NCDs; particularly mental disorders) were the leading causes of disease burden and mortality (64·8% of DALYs and 43·9% of deaths). Unintentional and transport injuries were also leading causes of death (14·7% of deaths due to transport injury and 13·3% of deaths due to unintentional injury) and leading causes of disease burden particularly among males in south-eastern Asia. In Melanesia, Micronesia, and some parts of south-eastern Asia (Cambodia, Indonesia, Laos, the Philippines, and Timor-Leste), respiratory infections and tuberculosis remained important contributors. Southern Asia had the largest reduction (1·5% per year) in all-cause DALYs over the study period, and Australia and New Zealand (0·2% per year) had the smallest, with females in Australia and New Zealand showing a slight increase contrary to regional trends. Eastern Asia had the largest reduction (2·8% per year) in all-cause mortality rate and Melanesia (0·8% per year) the smallest. Risk factors generally had between-subregion and within-subregion variation; however, some regional trends stood out, with overweight and obesity increasing in all countries across the region, and binge drinking increasing in more countries than not. In 2023, prevalence of smoking in males exceeded that in females in every country, from 40% difference in Timor-Leste to less than 1% difference in Australia. Anaemia prevalence is decreasing in all countries, but female prevalence was higher and reducing at a slower rate than in males. Bullying prevalence was slightly higher in Polynesia, Micronesia, and Melanesia combined, Australia and New Zealand, and eastern Asia compared with southern and south-eastern Asian subregions. INTERPRETATION: Several patterns were consistent across the region: the dominance of mental disorders and NCDs, the universal rise in overweight and obesity (particularly high in Oceanic countries but increasing rapidly in south and south-eastern Asia), and persistent sex-specific challenges across subregions: unintentional injuries and smoking in males, and anaemia in females. Actions to tackle shared risk factors (while accounting for context-specific local health profiles, workforce deficits, cultural factors, and health system capacity) should not be forgone due to local variation. Future research could focus on subnational variation, intersecting inequalities, and multi-sectoral interventions targeting shared risk factors. Priority actions should include regional investment in adolescent mental health services and obesity prevention, targeted injury reduction strategies for high-risk populations, and sex-specific approaches to smoking cessation and anaemia reduction, delivered through local health systems with the capacity and cultural responsiveness to meet local needs. FUNDING: Gates Foundation and Australian Government.
adolescent healthdisease burdenadolescent mortalitydisability-adjusted life years
Asian Pacific Journal of Cancer Prevention · vol. 27 (8) · 2853-2860
BACKGROUND: Retinoblastoma (Rb) represents the most frequent primary intraocular cancer in the pediatric population; yet comprehensive national data are limited in Saudi Arabia due to incomplete cancer registry coverage and underreporting. The present study systematically investigates the incidence, distribution, and trends of retinoblastoma across Saudi Arabia over two decades, utilizing robust data from the Saudi National Cancer Registry (SCR), a nationwide surveillance system overseen by the Ministry of Health. METHODS: This retrospective population-based analysis included all children diagnosed with Rb in Saudi Arabia between January 1, 2000, and December 31, 2019. The study examined incidence rates and temporal patterns by age, regional location, and tumor histology. RESULTS: Out of 542 documented cases (258 females, 284 males), the age-standardized incidence rate (ASIR) for children aged 0-4 years demonstrated an initial increase, peaking at 1.26 per 100,000 in 2003, followed by a gradual decline to 0.93 per 100,000 by 2019. Higher incidence rates were detected in major urban centers, especially Riyadh and Makkah, likely reflecting demographic density, enhanced diagnostic practices, and more accessible specialized care. Most tumors were either undifferentiated (Grade IV) or not otherwise specified (NOS, 63%), while diffuse retinoblastoma was rare (2%). Diagnosis was predominantly confirmed by histopathological evaluation (88.3%). CONCLUSION: This study offers the most comprehensive picture to date of retinoblastoma incidence and patterns in Saudi Arabia. The observed rising incidence, together with regional disparities, emphasizes the need for more refined cancer surveillance, equitable resource allocation, and accelerated early detection strategies, particularly in underserved areas. These findings provide essential baseline metrics to inform national cancer control policies and optimize equitable resource distribution.
retinoblastomapediatric cancer incidenceSaudi Arabiaage-standardized incidence rate
Progress in Disaster Science · vol. 31 · 100630-100630
Background Disaster preparedness in long-term care (LTC) hospitals is critical, as these facilities house vulnerable populations with complex care needs. Objectives To assess disaster management knowledge and preparedness among nurses in an LTC hospital in Riyadh, Saudi Arabia, and to examine the influence of sociodemographic and professional characteristics. Methods A cross-sectional descriptive study of 116 registered nurses in a 128-bed LTC hospital in Riyadh. Data were collected via self-administered paper-based questionnaires during December 2025 using the Arabic Disaster Preparedness Evaluation Tool (DPET). Data were analyzed using IBM SPSS Statistics version 25. Results 85.3% of nurses demonstrated high preparedness in Knowledge (mean = 4.86, SD = 0.65) and Preparedness/Skills (mean = 4.89, SD = 0.70); 89.7% scored high in Post-Disaster Management (mean = 4.91, SD = 0.64). Prior training significantly improved knowledge ( p = 0.014, r = −0.23) and preparedness ( p = 0.024, r = −0.21). Experience was associated with post-disaster management ( p = 0.013, η 2 = 0.070). Conclusions High disaster preparedness was demonstrated. Mandatory LTC-specific training programs are recommended.
disaster preparednessdisaster managementnurseslong-term care hospitals
Health Services Insights · vol. 19 · 11786329261450733-11786329261450733
Introduction: The yearly observance of Ramadan, which includes prolonged daily fasting, presents a challenging scenario for patients with chronic illnesses, with existing studies presenting inconsistent findings on its metabolic implications. Objective: This study aimed to objectively measure the immediate and sustained impacts of Ramadan fasting on monthly mean Hemoglobin A1c (HbA1c), Systolic Blood Pressure (SBP), and Diastolic Blood Pressure (DBP) in a large, real-world cohort of Saudi Arabian patients with concomitant T2DM and HTN. Methods: A retrospective longitudinal study was carried out using electronic health record (EHR) data from a Saudi multi-facility healthcare system from December 2023 to May 2024. The analysis used a segmented regression for Interrupted Time Series (ITS) to estimate changes in outcomes, with Ramadan (March 2024) serving as the intervention point. Results: = .002), indicating a rebound impact. The reduction in SBP was not sustained, as it returned to pre-Ramadan levels in the months that followed. Conclusions: In this large Saudi cohort, Ramadan fasting was linked to transitory improvements in glycemic and blood pressure control. The ensuing rebound implies that, while fasting can be metabolically advantageous, the effects do not last without ongoing intervention. These results highlight the important necessity for rigorous post-Ramadan clinical follow-up to consolidate any gains made during the fasting period. These findings position Ramadan as a novel window for metabolic reset and a potential preventive opportunity against cardiorenal metabolic syndrome progression in high-risk populations.
Ramadan fastingtype 2 diabeteshypertensionglycemic control
BACKGROUND: Given the rising incidence of endometrial cancer in Saudi Arabia, the integration of high-cost therapeutics, such as dostarlimab (DSR), for primary advanced or recurrent (pA/rEC) disease necessitates rigorous economic appraisal. Therefore, this study aimed to evaluate the cost-utility of first-line dostarlimab plus carboplatin-paclitaxel (DSR + CP) versus placebo plus carboplatin-paclitaxel (PBO + CP) from the perspective of the Saudi healthcare payer. METHODS: A partitioned survival model was constructed to simulate patient prognosis across three health states: progression-free disease, progressive disease, and death. The model parameters were derived from the clinical efficacy data of the RUBY trial and the local cost inputs. The primary outcome was the incremental cost-effectiveness ratio (ICER), the robustness of which was evaluated via comprehensive deterministic and probabilistic sensitivity analyses to characterize parameter uncertainty. RESULTS: For the overall pA/rEC population, the DSR + CP regimen yielded an incremental 1.55 quality-adjusted life-years (QALYs) at an additional cost of $144,716, resulting in an ICER of $93,244 per QALY. Cost-effectiveness was more favorable in the mismatch repair deficient (dMMR) subgroup (ICER: $82,754/QALY) than in the mismatch repair proficient (pMMR) cohort (ICER: $132,571/QALY). The ICER is the most sensitive to the acquisition cost of the DSR. At a willingness-to-pay threshold of $90,000/QALY, the probability of DSR + CP being cost-effective was 83.9% for the dMMR subgroup. CONCLUSION: This economic evaluation indicates that DSR + CP constitutes a cost-effective intervention for pA/rEC within the dMMR subpopulation. These findings provide strong evidence for a tailored reimbursement policy that effectively utilizes resources by connecting clinical benefits with economic value in the management of pA/rEC.
Dogs are among the most widespread and beloved domestic animals worldwide. As close companions of humans, they are commonly exposed to the environment and to various vectors, making them potential reservoirs for a wide range of vector-borne pathogens. This study was aimed to determine the molecular prevalence and genetic diversity of Anaplasma (A.) ovis, Toxoplasma (T.) gondii and Theileria (T.) ovis among domestic dogs in Pakistan. A total of 275 canine blood samples were collected from five districts in Punjab, Dera Ghazi Khan (n = 57), Vehari (n = 7), Layyah (n = 34), Bahawalpur (n = 38) and Muzaffargarh (n = 139), during March till October 2024. Polymerase Chain Reaction (PCR) based analysis revealed that 8.7% (24/275), 16.7% (46/275) and 11.6% (32/275) dogs were infected with A. ovis, T. gondii and T. ovis, respectively. Co-infections involving two or all three pathogens were also detected. The presence of all three pathogens was confirmed through Sanger sequencing followed by BLAST analysis and the amplified genes were similar to the pathogenic sequences deposited from countries worldwide. Prevalence of all three pathogens varied significantly between the sampling sites. Theileria ovis infection varied significantly between the screened dog breeds. Data analysis revealed that male dogs had a significantly higher of A. ovis infection rate as compared to females (p = 0.008). Overall, our findings indicate moderate infection rates of A. ovis, T. gondii and T. ovis in dogs from Pakistan. These findings highlight the need to include local dog populations in future vector-borne disease surveillance programs across Pakistan, following the One Health approach.
Frontiers in Public Health · vol. 14 · 1768449-1768449
Background: Obesity remains a major global health challenge and a significant contributor to chronic diseases. This study aimed to assess knowledge, attitudes, and practices (KAP) related to obesity and to identify sociodemographic and clinical factors influencing these domains among individuals with obesity. Methods: A cross-sectional survey was conducted using a convenience, non-probability sampling method among individuals with obesity recruited from hospitals, health clinics, and community settings. Obesity-related knowledge, attitudes, and practices were assessed, and multinomial regression analyses were performed to identify factors associated with KAP outcomes. Results: A total of 419 participants were included, with a nearly equal gender distribution and a predominantly young adult population, most of whom had university-level education. Overall, 45.3% demonstrated satisfactory knowledge, 42.2% exhibited positive attitudes, and 43.0% reported effective practices regarding obesity management. Increasing age (OR = 1.361, 95% CI: 1.134-1.635) and higher education (OR = 2.417, 95% CI: 1.575-3.710) were significantly associated with satisfactory knowledge. Male participants were more likely to exhibit negative attitudes than females (OR = 1.909, 95% CI: 1.141-3.195), while individuals diagnosed with obesity were less likely to report non-satisfactory attitudes (OR = 0.495, 95% CI: 0.290-0.845). Effective practices were associated with age (OR = 1.296, 95% CI: 1.076-1.562) and obesity diagnosis (OR = 0.475, 95% CI: 0.278-0.811). Perceptions of nutritional value significantly influenced both knowledge (OR = 0.741, 95% CI: 0.571-0.961) and practices (OR = 0.384, 95% CI: 0.288-0.512). Conclusion: The findings highlight the role of key sociodemographic and clinical factors-particularly age, education, and obesity diagnosis-in shaping obesity-related knowledge, attitudes, and practices. Targeted educational and behavioral interventions, especially among younger individuals and males, along with improved awareness of nutritional value, may enhance obesity management outcomes.
obesityknowledge, attitudes and practicesobesity treatmentsociodemographic factors
= 1.79 ± 0.05 µM), supporting its targeted anti-angiogenic mechanism. Flow cytometry analysis showed that 7e induced G0/G1 cell cycle arrest and markedly increased apoptotic cell populations. This was further confirmed by upregulation of Bax, Caspase-3, and Caspase-8, alongside downregulation of Bcl-2, indicating activation of both intrinsic and extrinsic apoptotic pathways. Interestingly, 7e inhibited cancer cell migration, suggesting a potential anti-angiogenetic effect. Density functional theory (DFT) calculations revealed that 7e possesses a conjugated electronic system with a suitable frontier orbital distribution, moderate HOMO-LUMO gap, and a favorable electrostatic potential for receptor interaction. Molecular docking and dynamics simulations demonstrated stable binding of 7e within the VEGFR-2 active site, supported by consistent RMSD, hydrogen bonding, and compact structural behavior. MM-GBSA calculations confirmed favorable binding free energy, while per-residue decomposition and protein-ligand interaction fingerprint analysis identified key stabilizing interactions. Essential dynamics and free energy landscape mapping further confirmed a stable and energetically favorable conformational state. ADMET and toxicity predictions indicated acceptable pharmacokinetic properties, low mutagenic risk, and an overall favorable safety profile. Collectively, these findings identify compound 7e as a promising VEGFR-2-targeted anticancer lead with strong enzymatic inhibition, potent cytotoxicity, and a well-supported mechanistic profile integrating experimental and computational evidence.
Archives of Endocrinology and Metabolism · vol. 70 (5) · 1-21
Objective: To quantify hepatic steatosis and visceral adiposity in active Cushing’s syndrome (CS) using magnetic resonance imaging (MRI), evaluate associations between hypercortisolism and MRI-derived fat metrics, and characterize the relationship between hepatic and visceral fat compartments. Subjects and methods: This retrospective cross-sectional study assessed 36 patients with biochemically confirmed active CS. Hepatic proton density, fat fraction, and visceral adipose tissue area were quantified using chemical-shift encoded MRI with semi-automated segmentation. Biochemical assessments included serum cortisol, adrenocorticotropic hormone, liver enzymes, and lipid profiles. Results: MRI-defined hepatic steatosis (fat fraction ≥6.25%) was identified in 69.4% (25/36) of patients. Those with steatosis exhibited higher serum cortisol levels (832.9 ± 347.8 vs. 581.2 ± 331.9 nmol/L, p = 0.049) and greater visceral adiposity (35.0 ± 8.0 vs. 23.9 ± 6.7 cm2, p < 0.001). Serum cortisol positively correlated with visceral fat area (r = 0.512, p = 0.001) and inversely correlated with liver signal intensity index (r = -0.424, p = 0.01). Visceral adiposity demonstrated a strong positive correlation with hepatic steatosis grade (r = 0.601, p < 0.001). Conclusion: Hepatic steatosis was highly prevalent in active CS and closely linked to hypercortisolism and visceral adiposity. These findings support a mechanistic coupling between central and ectopic fat accumulation. Integrated MRI-based fat quantification provides a non-invasive, radiation-free approach for refined cardiometabolic risk stratification in this high-risk population.
Background: Fournier’s gangrene is a rapidly progressive infection requiring coordinated emergency diagnosis, resuscitation, antimicrobial treatment, and surgical source control. Early manifestations overlap with less severe perineal infections, creating substantial diagnostic uncertainty. This review examined diagnostic and management evidence relevant to emergency department practice. Methods: Publications available through 31/05/2026 were evaluated using an explicit clinical framework. Eleven original reports addressing imaging, prognostic assessment, surgical timing, antimicrobial duration, hyperbaric oxygen, wound management, and fecal diversion were summarized. Findings were synthesized narratively because study designs, treatment selection, and outcome definitions differed. Results: Computed tomography demonstrated anatomical disease extent, although imaging findings from confirmed cases did not establish diagnostic accuracy in unselected emergency populations. Prognostic scores identified physiological disturbance without replacing clinical assessment or operative diagnosis. Earlier debridement was associated with lower mortality, including mortality of 2.6% versus 27.7% for surgery within versus after twelve hours in one cohort. Shorter antimicrobial courses following source control were not associated with worse outcomes in a retrospective study. Hyperbaric oxygen, negative pressure wound therapy, and fecal diversion produced favorable findings in selected cohorts, with substantial uncertainty from nonrandom treatment allocation. Conclusions: Emergency management prioritizes early surgical involvement, immediate broad spectrum antimicrobials, physiological stabilization, and prompt debridement. Imaging and prognostic tools support decisions without postponing source control. Adjunctive interventions require individualized selection, while prospective comparative research remains essential for defining their benefits.
Fournier's gangreneperineal soft tissue infectionemergency department managementsurgical debridement
Background: Emergency discharge is an established option for selected adults with uncomplicated acute diverticulitis. Treatment failure is difficult to predict accurately. This focused review examined baseline clinical, laboratory, and computed tomography predictors alongside outpatient outcomes. Methods: Original studies published through 31 May 2026 were examined for computed tomography confirmation, outpatient management, and subsequent deterioration. Ten outpatient studies were summarized descriptively. Broader prognostic cohorts were considered separately because their populations and outcomes differed from immediate emergency discharge. Results: Selected outpatient cohorts recorded low admission rates, including 2/70, 3/66, 4/155, and 4/140 patients in four studies. A randomized outpatient trial recorded hospitalization in 8/242 participants without antibiotics and 14/238 receiving antibiotics. Persistent pain and oral intolerance accounted for several treatment escalations. Imaging associations were imprecise and differed between studies. Different outcome definitions and follow-up periods restricted comparisons of failure frequencies across treatment protocols. Broader cohorts identified free fluid, female sex, elevated C-reactive protein, systemic comorbidity, vomiting, and prolonged symptoms as prognostic signals. Conclusions: Outpatient outcomes were better after structured selection and follow-up. Inflammatory burden, imaging abnormalities, and symptom persistence warrant particular attention. The data supports individualized assessment rather than a universal discharge score, with explicit separation of readmission, complicated progression, and recurrent episodes when interpreting treatment failure across different clinical settings.
acute diverticulitisuncomplicated diverticulitistreatment failurepredictors of treatment failure
Cell Biochemistry and Function · vol. 44 (10) · e70321-e70321
Patient-derived organoids (PDOs) have emerged as an effective experimental platform for bridging the long-standing gap between traditional in vitro cancer models and the biological complexity of actual tumors. These three-dimensional cultures (3D), derived directly from patient tissues, preserve essential architectural, genomic, and phenotypic characteristics of their tumors of origin, enabling more accurate modeling of tumor heterogeneity and disease evolution. Over the last decade, rapid methodological advances in organoid culture systems, extracellular matrices (ECMs), and growth factor optimization have facilitated the establishment of organoid models for a wide range of malignancies and the development of large living biobanks representing diverse patient populations. These models are increasingly being utilized to study cancer biology, elucidate mechanisms of treatment resistance, and evaluate patient-specific therapeutic responses, highlighting their potential as tools for precision oncology. However, important challenges remain, including incomplete representation of the tumor microenvironment (TME), variability in culture conditions, and limited scalability, and the need for greater standardization and validation. Consequently, although PDOs show considerable promise for translational research and personalized medicine, their routine clinical implementation remains largely investigational, and their clinical utility has not yet been fully established. This review examines the technological foundations of PDO generation, assesses their role as experimental models of tumor biology, and discusses their expanding applications in translational cancer research and precision oncology while highlighting key challenges that must be addressed before their widespread clinical adoption.
Journal of Cardiovascular Development and Disease · vol. 13 (10) · 478-478
Background: Tricuspid regurgitation (TR) increases mortality but remains undertreated due to high surgical risks. Transcatheter tricuspid valve interventions (TTVI) offer safer alternatives, improving functional status and quality of life. However, many candidates for TTVI have trans-tricuspid CIED leads that may interfere with procedural imaging and device deployment and may be exposed to dislodgement, entrapment, or jailing. Evidence regarding both clinical outcomes and postprocedural CIED function in this population remains limited. Existing trial evidence for this population is scarce, requiring further safety analysis. To our knowledge, this is the first meta-analysis to address the comparative risk of complications and residual TR in patients with vs. without CIEDs. Methods: We searched for relevant articles up to March 2026 from PubMed, Scopus, Cochrane Library, and Web of Science. Two independent reviewers extracted data from the selected studies, including baseline information, outcomes, comorbidities, hospitalization metrics, TR severity, and complications. All data analyses were performed using R version 4.4.1. Results: Ten studies comprising 5415 patients were included. Nine comparative studies contributed to the quantitative synthesis, whereas one single-arm study contributed only to the narrative synthesis of CIED-specific mechanical and electrical outcomes. In patients undergoing TTVI, across two studies, patients with CIEDs had a nominally lower risk of single-leaflet device attachment (RR 0.34, 95% CI 0.12–0.94; nominal p = 0.037); however, this exploratory finding should be considered hypothesis-generating. However, no statistically significant differences were observed between groups for cardiovascular death (RR 1.30, p = 0.815), device embolization (RR 1.62, p = 0.666), device malposition (RR 1.10, p = 0.909), stroke (RR 0.52, p = 0.335), hospitalization for heart failure (RR 1.02, p = 0.931), in-hospital mortality (RR 1.02, p = 0.959), major adverse events (RR 0.74, p = 0.635), major bleeding (RR 0.70, p = 0.187), or residual tricuspid regurgitation of mild (RR 0.98, p = 0.686) or moderate severity (RR 1.01, p = 0.646). CIED-specific outcomes were reported heterogeneously. Lead function was generally preserved after T-TEER in carefully selected patients, whereas studies of TTVR with jailed leads reported lead failure or malfunction ranging from 5.8% to 21% in individual cohorts. Conclusions: Among the comparative outcomes available for quantitative pooling, no statistically significant differences were detected between patients with and without CIEDs for most procedural and postprocedural outcomes. However, CIED-specific risks differed according to the intervention. Lead function was generally preserved after T-TEER in carefully selected patients, whereas lead jailing during TTVR was associated with clinically relevant lead malfunction in some cohorts. Therefore, the absence of significant differences in pooled clinical outcomes should not be interpreted as evidence that TTVI does not affect CIED function.